CJKHD's Avatar

CJKHD

@cjkhd.bsky.social

CJKHD, the official journal of CSN. We publish fundamental science and clinical science in the field of kidney health. Based in Canada|Turtle Island, we recognize our reparative responsibility to uplift the knowledges and expertise of Indigenous peoples.

1,227 Followers  |  1,107 Following  |  115 Posts  |  Joined: 22.11.2024
Posts Following

Posts by CJKHD (@cjkhd.bsky.social)

Figure 1. SWEET pilot study design.

Figure 1. SWEET pilot study design.

Can #sucralose enhance #Treg cells? The SWEET trial investigates! #transplant @facmed-umontreal.bsky.social l @csnscn.bsky.social @cjkhd.bsky.social

doi.org/10.1177/2054...

26.02.2026 12:36 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Overview of the KRESCENT core curriculum revamp process

Overview of the KRESCENT core curriculum revamp process

See how @CIHR funding via the novel #HRTP grant evolved the core #KRESCENT 2.0 curriculum 🍁
#futurenephrologists #trainingprogram

@csnscn.bsky.social @cjkhd.bsky.social @ualberta.bsky.social @ubcmedicine.bsky.social

17.02.2026 16:58 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Can-SOLVE CKD pathway to implementation.

Can-SOLVE CKD pathway to implementation.

Improving access to living #kidneydonor transplantation: a #patientoriented approach to living donor and transplant processes.
#organawareness @lhsccanada.bsky.social a @csnscn.bsky.social

doi.org/10.1177/2054...

12.02.2026 13:58 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Sage Journals: Discover world-class research Subscription and open access journals from Sage, the world's leading independent academic publisher.

Beyond the Equation: A Call for Sustained Equity in #CKD Care for Black Communities. ❀️ #EDI #BlackHealthMatters @sunnybrookhsc.bsky.social @csnscn.bsky.social

doi.org/10.1177/2054...

10.02.2026 18:34 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Conceptual framework of effect of intradialytic exercise on patient-important outcomes.

Conceptual framework of effect of intradialytic exercise on patient-important outcomes.

#Cardioprotective intradialytic exercise training may protect against hemodialysis-induced myocardial stunning, and improve patient-important outcomes #patientcare #AskRenal @umanitoba.bsky.social @csnscn.bsky.social

doi.org/10.1177/2054...

02.02.2026 14:11 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Overview of categories and subcategories pertaining to patient and caregiver transplant experiences.

Overview of categories and subcategories pertaining to patient and caregiver transplant experiences.

Kidney #transplantation in children with #kidneydisease: navigating the experiences and educational needs of patients and caregivers πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ #pediatricnephrology @usask.ca @sagepub.com @csnscn.bsky.social

doi.org/10.1177/2054...

29.01.2026 16:58 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Kidney biopsy findings at initial diagnosis of thrombotic microangiopathy (A, B) and postoperative renal cortical necrosis (C, D, E). Initial kidney biopsy reflecting thrombotic microangiopathy: (A) Glomerulus showing features of acute thrombotic microangiopathy: dilated capillary loops, mesangiolysis (white star) and fibrin thrombus (white arrow). In addition, periglomerular fibrosis due to chronic hypoperfusion. PAS 40Γ—. (B) Ultrastructural features of chronic microangiopathy: subendothelial widening by fluffy proteinaceous material separating the endothelial cell from the GBM (white star) and forming double contours (white arrow). Endothelial cell hypertrophy (orange star) (TEM 20000Γ—). Postoperative kidney biopsy: (C) Extensive necrosis (coagulative) with interstitial hemorrhage (white arrows). (H&E 20Γ—). (D) Coagulative necrosis, interstitial inflammation (white arrows) in areas of reperfusion (H&E, 20Γ—). (E) Extensive cortical necrosis (H&E 4Γ—).

Kidney biopsy findings at initial diagnosis of thrombotic microangiopathy (A, B) and postoperative renal cortical necrosis (C, D, E). Initial kidney biopsy reflecting thrombotic microangiopathy: (A) Glomerulus showing features of acute thrombotic microangiopathy: dilated capillary loops, mesangiolysis (white star) and fibrin thrombus (white arrow). In addition, periglomerular fibrosis due to chronic hypoperfusion. PAS 40Γ—. (B) Ultrastructural features of chronic microangiopathy: subendothelial widening by fluffy proteinaceous material separating the endothelial cell from the GBM (white star) and forming double contours (white arrow). Endothelial cell hypertrophy (orange star) (TEM 20000Γ—). Postoperative kidney biopsy: (C) Extensive necrosis (coagulative) with interstitial hemorrhage (white arrows). (H&E 20Γ—). (D) Coagulative necrosis, interstitial inflammation (white arrows) in areas of reperfusion (H&E, 20Γ—). (E) Extensive cortical necrosis (H&E 4Γ—).

A #casereport and #literaturereview of renal cortical necrosis due to antiphospholipid syndrome. πŸ”¬ #biopsy #necrosis #AKI @unityhealthto.bsky.social @csnscn.bsky.social

doi.org/10.1177/2054...

28.01.2026 13:59 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
CSN-QUIS nephrology fellow QI curriculum.

CSN-QUIS nephrology fellow QI curriculum.

The CSN-QUIS committee is expanding the QI curriculum for Nephrology trainees in Canada πŸ‡¨πŸ‡¦. #trainingprograms #positiveexperience #implementationscience

@csnscn.bsky.social @dalhousieu.bsky.social @sagepublishing.bsky.social

doi.org/10.1177/2054...

20.01.2026 17:06 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
CKD prevalence varies across Latin America. Among individual studies: Argentina 24.16%, Haiti 27.14%, Nicaragua 9.14%, Peru 16.83%, Panama 12.00%, Cuba 9.63%, Ecuador 7.26%. In countries with multiple studies: Brazil 13.91%, Mexico 20.79%, El Salvador 15.31%, Chile 20.58%. #CKD #Epidemiology

CKD prevalence varies across Latin America. Among individual studies: Argentina 24.16%, Haiti 27.14%, Nicaragua 9.14%, Peru 16.83%, Panama 12.00%, Cuba 9.63%, Ecuador 7.26%. In countries with multiple studies: Brazil 13.91%, Mexico 20.79%, El Salvador 15.31%, Chile 20.58%. #CKD #Epidemiology

Our systematic review suggests #CKD is a growing challenge in Latin America, with a prevalence of 15.9%.

Global diagnostic criteria and prevention strategies for vulnerable populations are urgently needed. #KidneyHealth #Epidemiology @csnscn.bsky.social @sagepub.com

doi.org/10.1177/2054...

19.01.2026 13:08 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
PRECIS-2 wheel highlighting the pragmatism of the Dial-Mag trial for 9 domains.

PRECIS-2 wheel highlighting the pragmatism of the Dial-Mag trial for 9 domains.

A pragmatic trial to inform center-wide policy on the optimal dialysate magnesium concentration for patient health. #hemodialysis #DialMag #healthcare @csnscn.bsky.social

doi.org/10.1177/2054...

15.01.2026 18:09 β€” πŸ‘ 4    πŸ” 1    πŸ’¬ 0    πŸ“Œ 1
Figure 1. Main themes and practical considerations when implementing incremental hemodialysis.

Figure 1. Main themes and practical considerations when implementing incremental hemodialysis.

Patients’ and healthcare providers’ experiences with incremental #hemodialysis: our qualitative study outlines benefits, challenges, and practical recommendations for safe implementation. #MUHC #Nephrology #QualityofLife
@mcgilluniversity.bsky.social

doi.org/10.1177/2054...

14.01.2026 12:12 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Summary of components of the protocol-based fluid management prescription.

Summary of components of the protocol-based fluid management prescription.

A pragmatic trial to inform center-wide policy on the optimal dialysate magnesium concentration for patient health. #hemodialysis #DialMag
@crchum.bsky.social
@csnscn.bsky.social

doi.org/10.1177/2054...

05.01.2026 11:34 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Prevalence of individuals with a multidisciplinary visit under the GN model of care.

Prevalence of individuals with a multidisciplinary visit under the GN model of care.

Filling the gaps in #glomerulonephritis care: Ontario Renal Network’s new multidisciplinary model to improve access to timely and effective multidisciplinary GN care. #OntarioHealth
@sunnybrookhsc.bsky.social @cjkhd.bsky.social
@csnscn.bsky.social

doi.org/10.1177/2054...

24.12.2025 13:42 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Sage Journals: Discover world-class research Subscription and open access journals from Sage, the world's leading independent academic publisher.

Desmopressin for #kidneybiopsy in patients with #CKD has efficacy for reducing bleeding outcomes. Despite this, it does not completely mitigate the increased bleeding risk of lower GFR levels (≀stage 3b) and is not a panacea for this outcome. @csnscn.bsky.social

doi.org/10.1177/2054...

16.12.2025 12:23 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Person-level or individual factors that contribute to inequitable impacts of disasters

Person-level or individual factors that contribute to inequitable impacts of disasters

From Risk and Vulnerability to Preparedness and Resiliency: An Opinion Piece on Championing Disaster and Emergency Risk Reduction and Management in #KidneyCare. @csnscn.bsky.social @cjkhd.bsky.social @mcgilluniversity.bsky.social

doi.org/10.1177/2054...

24.11.2025 13:02 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Multifaceted QI intervention to reduce time to transplant listing

Multifaceted QI intervention to reduce time to transplant listing

A QI intervention showed early signs of success in reducing time to #kidneytransplant listing and improved access for #Indigenous patients at an academic tertiary care center. @mcgilluniversity.bsky.social @cjkhd.bsky.social @csnscn.bsky.social

doi.org/10.1177/2054...

18.11.2025 12:26 β€” πŸ‘ 3    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Self-reported nephrology fellow kidney POCUS skill level. (A) Pre-workshop, (B) Post-workshop.

Self-reported nephrology fellow kidney POCUS skill level. (A) Pre-workshop, (B) Post-workshop.

#Nephrology fellows trained in #POCUS can detect hydronephrosis & small kidneys with high specificity!

A structured workshop improves confidence, speeds up imaging,& enhances patient satisfaction #kidneyweek @unityhealthto.bsky.social @csnscn.bsky.social @cjkhd.bsky.social

doi.org/10.1177/2054...

17.11.2025 13:21 β€” πŸ‘ 4    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Figure 2. A summary of the key insights gained during this participatory research that helped inform the methods of a large multinational qualitative research study that we will undertake to unpack the contributors of gender disparity in living kidney donation in different societies and health systems.

Figure 2. A summary of the key insights gained during this participatory research that helped inform the methods of a large multinational qualitative research study that we will undertake to unpack the contributors of gender disparity in living kidney donation in different societies and health systems.

Unpacking the contributors of #genderdisparity in living #kidneydonation in different societies and health systems: key insights gained @csnscn.bsky.social @mcgilluniversity.bsky.social

doi.org/10.1177/2054...

04.11.2025 12:34 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
A table with columns headers β€œtheme” and β€œsupporting statement”. The theme column list the major themes found in the study interviews. The supporting statements column list examples of participant quotes that describe the associated theme.

A table with columns headers β€œtheme” and β€œsupporting statement”. The theme column list the major themes found in the study interviews. The supporting statements column list examples of participant quotes that describe the associated theme.

Weight management in #CKD patients is key to transplantation eligibility. 12 patients discuss lack of support, family eating habits, endurance, and values of quality of life as key factors to consider. #kidneydisease #obesity @westernu.ca @csnscn.bsky.social

doi.org/10.1177/2054...

30.10.2025 16:54 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Summary of sex and gender characteristics of adults on hemodialysis experiencing depression and depressive symptoms (n = 25).

Summary of sex and gender characteristics of adults on hemodialysis experiencing depression and depressive symptoms (n = 25).

A scoping review found more differences than similarities in #sexandgender related to depression in #hemodialysis patients. Notably higher rates of #depression was observed in females. #kidneyfailure @csnscn.bsky.social @cjkhd.bsky.social @ualberta.bsky.social

doi.org/10.1177/2054...

27.10.2025 11:20 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Reasons for non-usage of evidence-based therapies in the C.a.R.E clinic.

Reasons for non-usage of evidence-based therapies in the C.a.R.E clinic.

Barriers to uptake of evidence-based therapies in the C.a.R.E clinic. @UHN @CSNSCN #kidneyhealth #MedEd

doi.org/10.1177/2054...

22.10.2025 11:04 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
My Kidneys My Health - Living Well with Chronic Kidney Disease Your comprehensive guide to living well with Chronic Kidney Disease (CKD). Explore diet, medications, symptoms, mental health, and daily life management resources.

The CanSolveCKD team is adapting mykidneysmyhealth.com to better support diverse communities with #CKD. Through patient-oriented research, Indigenous engagement & inclusive design, they're improving access, cultural relevance & sexual health support @csnscn.bsky.social

doi.org/10.1177/2054...

21.10.2025 12:35 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

This pragmatic randomized control trial determined whether the addition of a virtual monitoring platform can reduce emergency department visits and hospitalizations in advanced #CKD patients. @csnscn.bsky.social @umanitoba.bsky.social

doi.org/10.1177/2054...

20.10.2025 11:15 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

A #NarrativeReview identifies key barriers that limit the donation of #kidneygrafts after death and proposes different initiatives for potentially expanding the donor pool. #organdonation @mcmasteruniversity.bsky.social @sickkidsto.bsky.social @csnscn.bsky.social

doi.org/10.1177/2054...

17.10.2025 12:41 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
This figure shows the therapies used by individuals classified as having moderate-to-severe CKD-aP. Of those with moderate-to-severe CKD-aP, 29% were using over-the-counter medications, 1% were using cannabinoids, 9% were taking prescribed Gabapentin or Pregabalin, and 18% were using a combination of these therapies (of these patients 1 was prescribed antihistamines in addition to other treatments). 42% were using no treatments.

This figure shows the therapies used by individuals classified as having moderate-to-severe CKD-aP. Of those with moderate-to-severe CKD-aP, 29% were using over-the-counter medications, 1% were using cannabinoids, 9% were taking prescribed Gabapentin or Pregabalin, and 18% were using a combination of these therapies (of these patients 1 was prescribed antihistamines in addition to other treatments). 42% were using no treatments.

The impact of #chronickidneydisease -associated pruritus on quality of life, gaps in care, and the importance of systematic symptom screening. #dialysis @queensuresearch.bsky.social @csnscn.bsky.social

doi.org/10.1177/2054...

14.10.2025 11:29 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Figure 4. Mean serum 25(OH)D levels from supplement vs non-supplement groups.

Figure 4. Mean serum 25(OH)D levels from supplement vs non-supplement groups.

Calcium isn’t just about bones. In dialysis patients, high serum calcium with low #vitaminD meant weaker muscles; supplements helped. Time to rethink calcium’s neuromuscular role. #CalciumMetabolism #Nephrology #Sarcopenia @cjkhd.bsky.social @csnscn.bsky.social

doi.org/10.1177/2054...

10.10.2025 15:01 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Figure 2. Montreal cognitive assessment (MoCA).

Figure 2. Montreal cognitive assessment (MoCA).

A #clinicalresearch protocol looks at the prevalence of cognitive impairment in patients undergoing hemodialysis using #VirtualReality cognitive testing
@umanitobasci.bsky.social @dalhousieu.bsky.social @csnscn.bsky.social

doi.org/10.1177/2054...

07.10.2025 11:57 β€” πŸ‘ 2    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Figure 1. The KRESCENT mentorship team spans across jurisdictions, sectors, and disciplines.
1. Todd Alexander (NPA). KRESCENT Program Director. 2. Adeera Levin (PA), KRESCENT leadership since inception. 3. Sunny Hartwig (PA), KRESCENT Curriculum Chair and KRESCENT alumna. 4. Julie Ho (PA), KRESCENT alumna. 5. Leanne Stalker (PA), Scientific Director of KFoC. 6. Janine Farragher (PA), ECR and KRESCENT alumna. 7. Mary Beaucage (PA), Patient Council member. 8. Kara Schick-Makaroff (PA), KRESCENT alumna. 9. Malcolm King (PA) Indigenous Scholar and former head of the CIHR Institute of Aboriginal Health. 10. Sanjay Pandeya (PA), President of the CSN. 11. Karthik Tennankore (PA). 12. Ana Konvalinka (PA), KRESCENT alumna. 13. Kevin Burns (PA), KRESCENT Founder and former Director. 14. FranΓ§ois Madore (PA). 15. Nina Jones (Co-App), KRESCENT alumna. 16. Robert Quinn (Co-App). 17. Lisa Robinson (Co-App) EDI Champion. 18. Morteza Ahmadi (Co-App), KRESCENT alumni entrepreneur. 19. Mitch Abrams (Co-App).

Figure 1. The KRESCENT mentorship team spans across jurisdictions, sectors, and disciplines. 1. Todd Alexander (NPA). KRESCENT Program Director. 2. Adeera Levin (PA), KRESCENT leadership since inception. 3. Sunny Hartwig (PA), KRESCENT Curriculum Chair and KRESCENT alumna. 4. Julie Ho (PA), KRESCENT alumna. 5. Leanne Stalker (PA), Scientific Director of KFoC. 6. Janine Farragher (PA), ECR and KRESCENT alumna. 7. Mary Beaucage (PA), Patient Council member. 8. Kara Schick-Makaroff (PA), KRESCENT alumna. 9. Malcolm King (PA) Indigenous Scholar and former head of the CIHR Institute of Aboriginal Health. 10. Sanjay Pandeya (PA), President of the CSN. 11. Karthik Tennankore (PA). 12. Ana Konvalinka (PA), KRESCENT alumna. 13. Kevin Burns (PA), KRESCENT Founder and former Director. 14. FranΓ§ois Madore (PA). 15. Nina Jones (Co-App), KRESCENT alumna. 16. Robert Quinn (Co-App). 17. Lisa Robinson (Co-App) EDI Champion. 18. Morteza Ahmadi (Co-App), KRESCENT alumni entrepreneur. 19. Mitch Abrams (Co-App).

The KRESCENT 2.0 Health Research Training Platform grant process represents a pan-Canadian effort to fund the next generation of kidney scientists through the KRESCENT platform. #kidneydisease #kidneydiseaseawareness #kidneyhealth @csnscn.bsky.social @cjkhd.bsky.social

doi.org/10.1177/2054...

06.10.2025 18:26 β€” πŸ‘ 3    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
A comparative summary of KRESCENT training offerings - from beginning to present (KRESCENT 1.0 to 2.0)

A comparative summary of KRESCENT training offerings - from beginning to present (KRESCENT 1.0 to 2.0)

KRESCENT; 2005 -2025 – 20 years! Editorial

#CureKidneyDisease #KRESCENT #Mentoring

@csnscn.bsky.social @cjkhd.bsky.social @ualberta.bsky.social
@ubcmedicine.bsky.social

doi.org/10.1177/2054...

02.10.2025 18:37 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Table 1. Cox-Regression Analysis of Kidney-Related Outcomes After Prescription of Anti-Hyperglycemic Medications.

Table 1. Cox-Regression Analysis of Kidney-Related Outcomes After Prescription of Anti-Hyperglycemic Medications.

Cox-regression analysis of kidney-related outcomes after prescription of anti-hyperglycemic medications.
#diabetes #kidneydisease #protection @csnscn.bsky.social @cjkhd.bsky.social @ualberta.bsky.social

doi.org/10.1177/2054...

24.09.2025 13:14 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0